| 注册
首页|期刊导航|器官移植|2024年中国肺移植基础研究年度盘点

2024年中国肺移植基础研究年度盘点

马吉尔 田东 朱峻民 张镧 靳小汉 郑翔匀 侯森林 喻赠玮 刘亚灵 严浩吉

器官移植2025,Vol.16Issue(3):386-393,8.
器官移植2025,Vol.16Issue(3):386-393,8.DOI:10.12464/j.issn.1674-7445.2025116

2024年中国肺移植基础研究年度盘点

Annual review of basic research on lung transplantation of China in 2024

马吉尔 1田东 2朱峻民 1张镧 1靳小汉 1郑翔匀 3侯森林 4喻赠玮 4刘亚灵 4严浩吉4

作者信息

  • 1. 610041 成都,四川大学华西临床医学院
  • 2. 四川大学华西医院胸外科||四川大学华西医院胸部肿瘤研究所肺移植研究室
  • 3. 四川大学华西医院胸外科
  • 4. 四川大学华西医院胸部肿瘤研究所肺移植研究室
  • 折叠

摘要

Abstract

Lung transplantation is the optimal treatment for end-stage lung diseases and can significantly improve prognosis of the patients.However,postoperative complications such as infection,rejection,ischemia-reperfusion injury,and other challenges(like shortage of donor lungs),limit the practical application of lung transplantation in clinical practice.Chinese research teams have been making continuous efforts and have achieved breakthroughs in basic research on lung transplantation by integrating emerging technologies and cutting-edge achievements from interdisciplinary fields,which has strongly propelled the development of this field.This article will comprehensively review the academic progress made by Chinese research teams in the field of lung transplantation in 2024,with a focus on the achievements of Chinese teams in basic research on lung transplantation.It aims to provide innovative ideas and strategies for key issues in the basic field of lung transplantation and to help China's lung transplantation cause reach a higher level.

关键词

肺移植/感染/排斥反应/免疫耐受/缺血-再灌注损伤/慢性移植肺功能障碍/宏基因组二代测序/原发性移植物功能障碍

Key words

Lung transplantation/Infection/Rejection/Immune tolerance/Ischemia-reperfusion injury/Chronic lung allograft dysfunction/Metagenomic next-generation sequencing/Primary graft dysfunction

分类

医药卫生

引用本文复制引用

马吉尔,田东,朱峻民,张镧,靳小汉,郑翔匀,侯森林,喻赠玮,刘亚灵,严浩吉..2024年中国肺移植基础研究年度盘点[J].器官移植,2025,16(3):386-393,8.

基金项目

国家自然科学基金(82470104) (82470104)

器官移植

OA北大核心

1674-7445

访问量0
|
下载量0
段落导航相关论文